SEC CIK 1297709
Novartis Bioventures Ltd
Reported ownership across 11 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| ALTview stock → | 8,345,145 | 2018-09-12 |
| NONEview stock → | 5,245,550 | 2017-03-15 |
| ARPOview stock → | 4,049,804 | 2019-04-26 |
| AKBAview stock → | 3,405,764 | 2014-03-25 |
| MRNAview stock → | 2,899,070 | 2010-07-21 |
| GRTXview stock → | 2,467,961 | 2020-06-19 |
| ALRNview stock → | 2,079,394 | 2019-04-01 |
| NASDAQ:ALTview stock → | 1,867,301 | 2017-05-04 |
| BCYCview stock → | 1,769,641 | 2019-05-28 |
| AKUSview stock → | 1,181,258 | 2020-06-30 |
| FMTXview stock → | 331,221 | 2020-06-18 |
Position History — AKBA
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — AKBA
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2014-03-25 | Conversion (derivative) | 347,831 | — | 0 |
| 2014-03-25 | Conversion (derivative) | 708,647 | — | 0 |
| 2014-03-25 | Conversion (derivative) | 257,031 | — | 0 |
| 2014-03-25 | Conversion | 3,223,174 | — | 3,405,764 |
| 2014-03-25 | Open-market buy | 182,590 | $17.00 | 182,590 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.